Collegium Pharmaceutical, Inc.
COLLNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 22, 2026 close
- Market cap
- $762.83M
- P/E (TTM)
- 15.92
- Forward P/E
- 14.11
- Dividend yield
- -
- 52-week range
- $21.43$50.79
- Volume (live)
- -
- Avg. volume (3M)
- 798.96K
Collegium Pharmaceutical (COLL) Stock Price & Financial Analysis
Collegium Pharmaceutical Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $22.94 - $23.85 |
|---|---|
| 52-Week High | $50.79 |
| 52-Week Low | $21.43 |
| Open | $23.03 |
| Volume (last close) | 738.76K |
| Average Volume (3M) | 798.96K |
| Revenue (TTM) | 808.21M |
|---|---|
| Net Income (TTM) | 47.91M |
| Free Cash Flow (TTM) | 328.28M |
| EPS (TTM) | $1.26 |
| Profit Margin | 5.93% |
| Operating Margin | 19.48% |
| Return on Equity (ROE) | 15.36% |
| Debt to Equity | 3.50 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 762.83M |
|---|---|
| Shares Outstanding | 32.46M |
| P/E Ratio (TTM) | 15.92 |
| Forward P/E | 14.11 |
| Price to Sales (P/S) | 0.94 |
| Price to Book (P/B) | 2.45 |
| EV/EBITDA | 4.45 |
| 50-Day MA | $23.99 |
|---|---|
| 200-Day MA | $34.18 |
| 1-Year Change | −33.88% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Collegium Pharmaceutical at a Glance
As of the Oct 22, 2026 close, Collegium Pharmaceutical (COLL) has a market capitalization of $762.83M. The stock trades at 15.9× trailing earnings, 14.1× forward earnings and 0.9× sales. Over the trailing twelve months it earned $47.91M on revenue of $808.21M (a 5.9% profit margin) and generated $328.28M of free cash flow. Revenue grew 14.3% year over year.
As of its latest reported balance sheet, it holds $129.47M in cash and securities against $1.09B of debt, a net debt position of $962.09M.
Collegium Pharmaceutical does not currently pay a dividend.
The share price is down 33.9% over the past year. At $23.50 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $21.43 to $50.79, below its 200-day moving average of $34.18.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $48.71, 107.3% above the Oct 22, 2026 close.
Frequently Asked Questions About Collegium Pharmaceutical
What is the current stock price for COLL?
As of the Oct 22, 2026 close, COLL stock trades at $23.50. The 52-week range is $21.43–$50.79, with a day range of $22.94–$23.85.
What is the P/E ratio for COLL?
As of the Oct 22, 2026 close, Collegium Pharmaceutical's trailing twelve-month (TTM) P/E ratio is 15.9, meaning investors pay $15.9 for every $1 of annual earnings. The forward P/E is 14.1, reflecting analyst expectations for future earnings. Collegium Pharmaceutical operates in the Healthcare sector.
Does COLL pay dividends?
Collegium Pharmaceutical does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for COLL?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for COLL is Buy. The average 12-month price target is $48.71, a 107.3% upside from the Oct 22, 2026 close of $23.50.
What is the market cap of COLL?
As of the Oct 22, 2026 close, Collegium Pharmaceutical's market capitalization is $762.8M, classifying it as a small-cap company. Collegium Pharmaceutical operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.